Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -4.1% | +29.8% | 2 / 3 | +29.0% | -1.70 pp | -3.82 pp | +11.9% | 0.44 | 8.89 | 1.239 | +29,0% | 131 | −5,3% | 8.89 | 10.55 | −15,8% |
| Pts | 0 | 4 | 8 | 12 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 30.950 (close price on 2026-10-19)EPS (TTM): 3.483
Financial charts
1.Revenue & growth
VND bn1.239Q2/26
1.Revenue & growth
VND bn1.239Q2/26
2.Profit & growth
VND bn132Q2/26
3.Profit mix (Penman)
VND bn671Q2/26
4.Margins & cost structure
%28.5%Q2/26
5.Returns & cash cycle
% · days13.2%Q2/26
6.Earnings quality & cash
VND bn-286Q2/26
7.Asset structure
VND bn8.350Q2/26
8.Funding & debt health
VND bn · times8.350Q2/26
9.Revenue backlog
VND bn176Q2/26
10.Valuation
times · %8,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %877Q2/26
Adjusted EPS growth, latest quarter
-4.1%
Average adjusted EPS growth, 3 quarters
29.8%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26